Triple-negative breast cancer: new perspectives for novel therapies
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Triple-negative breast cancer: new perspectives for novel therapies
Authors
Keywords
Triple-negative breast cancer, Biomarkers, Target therapy
Journal
MEDICAL ONCOLOGY
Volume 30, Issue 3, Pages -
Publisher
Springer Nature
Online
2013-07-04
DOI
10.1007/s12032-013-0653-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vaccinia Virus GLV-1h153 Is Effective in Treating and Preventing Metastatic Triple-Negative Breast Cancer
- (2012) Sepideh Gholami et al. ANNALS OF SURGERY
- MicroRNA-34a Modulates Chemosensitivity of Breast Cancer Cells to Adriamycin by Targeting Notch1
- (2012) Xiu-juan Li et al. ARCHIVES OF MEDICAL RESEARCH
- Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer
- (2012) Xiaofeng Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- 25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1
- (2012) Eitan Amir et al. BREAST CANCER RESEARCH AND TREATMENT
- Treatment of breast cancer stem cells with oncolytic herpes simplex virus
- (2012) J Li et al. CANCER GENE THERAPY
- Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells
- (2012) Ming Qiu et al. CANCER LETTERS
- Overexpression of enhancer of zeste homolog 2 (EZH2), focal adhesion kinase (FAK), and pFAK in high grade endometrial carcinoma
- (2012) A. Semaan et al. GYNECOLOGIC ONCOLOGY
- Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer
- (2012) Yaser R. Hussein et al. HUMAN PATHOLOGY
- Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells
- (2012) Huiqiang Wang et al. Journal of Translational Medicine
- Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer
- (2012) Claudia Piovan et al. Molecular Oncology
- Coordinated Regulation of Polycomb Group Complexes through microRNAs in Cancer
- (2011) Qi Cao et al. CANCER CELL
- EZH2 Promotes Expansion of Breast Tumor Initiating Cells through Activation of RAF1-β-Catenin Signaling
- (2011) Chun-Ju Chang et al. CANCER CELL
- MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer
- (2011) Jelena Radojicic et al. CELL CYCLE
- Prevalence and Prognostic Role of Triple-Negative Breast Cancer by Race: A Surveillance Study
- (2011) Helen Swede et al. Clinical Breast Cancer
- Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer
- (2011) Laszlo Otvos et al. EUROPEAN JOURNAL OF CANCER
- Expression of Leptin, Leptin Receptor, Adiponectin, and Adiponectin Receptor in Ductal CarcinomaIn Situand Invasive Breast Cancer
- (2011) Young-Ju Jeong et al. Journal of Breast Cancer
- Targeted therapies for breast cancer
- (2011) Michaela J. Higgins et al. JOURNAL OF CLINICAL INVESTIGATION
- Adeno-associated virus type 2 infection activates caspase dependent and independent apoptosis in multiple breast cancer lines but not in normal mammary epithelial cells
- (2011) Samina Alam et al. Molecular Cancer
- Down-regulation of Notch1 by gamma-secretase inhibition contributes to cell growth inhibition and apoptosis in ovarian cancer cells A2780
- (2010) Mingyi Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Regulation of Tumor Angiogenesis by EZH2
- (2010) Chunhua Lu et al. CANCER CELL
- Notch Signaling Proteins: Legitimate Targets for Cancer Therapy
- (2010) Zhiwei Wang et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Herpes simplex virus oncolytic vaccine therapy in melanoma
- (2010) Shanthi Sivendran et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Leptin as a potential therapeutic target for breast cancer prevention and treatment
- (2010) Amitbha Ray et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Oncolytic vaccinia virus: a theranostic agent for cancer
- (2010) Nanhai G Chen et al. Future Virology
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Obesity on Breast Cancer Development
- (2010) M. P. Cleary et al. VETERINARY PATHOLOGY
- Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer
- (2009) Karin Rennstam et al. BREAST CANCER RESEARCH AND TREATMENT
- High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors
- (2009) E. Manie et al. CANCER RESEARCH
- TargetingmiR-205in breast cancer
- (2009) Hailong Wu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- MicroRNAs in Cancer: Small Molecules With a Huge Impact
- (2009) Marilena V. Iorio et al. JOURNAL OF CLINICAL ONCOLOGY
- Insulin-Dependent Leptin Expression in Breast Cancer Cells
- (2008) V. Bartella et al. CANCER RESEARCH
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
- Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1
- (2008) M E Gonzalez et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started